Ph2 master protocol study to evaluate ABBV-400 in combo with subjects with mColorectal Cancer
Phase II Clinical Trial
A Phase 2 Open-Label Randomized Master Protocol Study to Evaluate Safety and Efficacy of Multiple Treatment Combinations with Telisotuzumab Adizutecan in Subjects with Metastatic Colorectal Cancer (AndroMETa-CRC-533) (M24-533)